Associate Director, Drug Development Project Manager – Early Assets (Hematology/Oncology/Cell Therapy) - Military Veterans

at Bristol Myers Squibb

San Diego, California

At Bristol Myers Squibb, we are inspired by a single vision – transforming patients’ lives through science. In oncology, hematology, immunology and cardiovascular disease – and one of the most diverse and promising pipelines in the industry – each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.

Associate Director, Drug Development Project Manager – Early Assets (Hematology/Oncology/Cell Therapy)

Early Development Project Managers (ED PMs) provide execution leadership for an asset or a portfolio of assets for a Therapeutic Area (TA)/Thematic Research Center (TRC). They partner with the Early Development Program Leads (EDPLs) to lead cross-matrix Early Development Program Teams (EDPTs) that are the hub of drug development activities at BMS, shaping and executing the drug development strategies from Candidate Declaration through Phase 2 Proof of Concept. The ED PMs sit in the Research & Early Development Project Management (R&ED PM) organization within R&D Strategy and Planning (RDSP). This role supports the portfolio of Hematology/Oncology/Cell Therapy assets. This position can sit in Cambridge; Princeton or Summit, NJ; Seattle; San Diego or Brisbane, CA; and allows for a hybrid work arrangement. **level is commensurate with experience, and determined during the interview process**

The Associate Director Early Development Project Manager (ED PM) is a seasoned project manager who is accountable for the cross-functional planning and execution of one or more drug development programs including definition of the operational strategy, management of timelines, cost, quality, and risk assessment and mitigation.  The ED PM provides an independent voice to shape the overall project strategy and drive optimal decisions for the broader portfolio value.   They also are champions of the project management role, and support, champion and execute on the R&ED PM and RDSP vision to enable an industry-leading PM organization.

Roles & Responsibilities:

  • The Early Development Project Manager (ED PM) is accountable for one or more EDPTs of moderate or high complexity and is highly autonomous in supporting the Hematology/Oncology/Cell Therapy portfolio as part of their day-to-day work. 
  • Partners with the Early Development Program Lead (EDPL) to lead a cross-functional matrix team of experts in advancing programs/assets within the remit of their Early Development Program Team (EDPT). Acts as an integrator within the EDPT and across the enterprise to ensure alignment on project strategy implementation in alignment with project priority, across all intended indications and for all geographies.
  • Accountable for creating and maintaining a cross-functional development plan, timeline and budget for each program and ensuring progress vs. plan.
  • Facilitates effective, science-based business decisions including development of scenarios (base-case, buy-ups, buy-downs) as needed, highlighting interdependencies and downstream impacts (including but not limited to timelines and budget) of strategic decisions
  • Proactively identifies and facilitates team review of program risks and ensures mitigation plans are developed and implemented.
  • Ensures all decisions are assessed as to their risks and impacts. Accountable for communication to team and stakeholders in a transparent and timely manner.
  • With the EDPL, works to foster a high performing team and monitor the health and operating efficiency of the team as a unit. Leads creation of team norms and operating principles with a focus on cross-functional input and accountability, and robust analysis of vetted options and decision making per guidance framework.
  • Coaches project team members and others to drive excellence and accountability, and develop talent pipeline for DPT membership.
  • Ensures appropriate DPT membership during the progression of the program.
  • Develops and coordinates resource and budget planning across functions to assure adequate resources are applied to the project and any changes are highlighted appropriately.
  • Advises on governance expectations and prepares for key decision point discussions with focus on cross-functional input, rigorous debate to enable efficient decision making.
  • For projects that are being jointly developed, works closely with a key strategic alliance partner.
  • As project management subject matter expert, understands best practices, identifies gaps and challenges, implements efficiencies and improved ways of working within R&ED PM and RDSP.
  • Acts as change agent for continuous improvement and transformational initiatives developed within R&ED PM and RDSP.


  • Advanced degree in Life Sciences, Chemical Sciences, Physical sciences or other relevant discipline., MS/Ph.D. preferred.
  • Minimum of 10-15 years of experience in biotech/pharmaceutical industry, preferably in the early development space, including 5 years in project/portfolio management or leadership of cross-functional matrix teams.
  • Demonstrated competency in early phase drug development expertise with solid understanding of disease area and drug development pathway with the ability to contribute to strategic discussions.  
  • Leadership skills including situational leadership, ability to lead a team of experts and influence without authority.
  • Demonstrated ability to lead matrix teams, knows how to work at the strategic level with the DPL and when to delve deeper to resolve issues and challenges.
  • Experience with commonly used project management tools including but not limited to Microsoft project.
  • Strong communicator able to integrate and succinctly summarize the various parts of a project and effectively tailor messages to audience incl. senior leaders.
  • Ability to resolve complex problems and manage difficult stakeholder situations.
  • Ability to lead the development of critical path analyses and scenario planning.
  • Excellent Project Management Skills – drives execution while balancing speed, quality, risk and cost.

Around the world, we are passionate about making an impact on the lives of patients with serious diseases. Empowered to apply our individual talents and diverse perspectives in an inclusive culture, our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. 

Physical presence at the BMS worksite or physical presence in the field is an essential job function of this role which the Company deems critical to collaboration, innovation, productivity, employee well-being and engagement, and enhances the Company culture.

To protect the safety of our workforce, customers, patients and communities, the policy of the Company requires all employees and workers in the U.S. and Puerto Rico to be fully vaccinated against COVID-19, unless they have received an exception based on an approved request for a medical or religious reasonable accommodation.  Therefore, all BMS applicants seeking a role located in the U.S. and Puerto Rico must confirm that they have already received or are willing to receive the full COVID-19 vaccination by their start date as a qualification of the role and condition of employment.  This requirement is subject to state and local law restrictions and may not be applicable to employees working in certain jurisdictions such as Montana. This requirement is also subject to discussions with collective bargaining representatives in the U.S.

Our company is committed to ensuring that people with disabilities can excel through a transparent recruitment process, reasonable workplace adjustments and ongoing support in their roles. Applicants can request an approval of accommodation prior to accepting a job offer. If you require reasonable accommodation in completing this application or if you are applying to a role based in the U.S. or Puerto Rico and you believe that you are unable to receive a COVID-19 vaccine due to a medical condition or sincerely held religious belief, during or any part of the recruitment process, please direct your inquiries to Visit to access our complete Equal Employment Opportunity statement.

BMS will consider for employment qualified applicants with arrest and conviction records, pursuant to applicable laws in your area.

Any data processed in connection with role applications will be treated in accordance with applicable data privacy policies and regulations.

San Diego, California

Bristol-Myers Squibb is a global BioPharma company firmly focused on its Mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

Around the world, our medicines help millions of people in their fight against such diseases as cancer, cardiovascular disease, diabetes, hepatitis B, HIV/AIDS, rheumatoid arthritis and psychiatric disorders.

At Bristol-Myers Squibb, our BioPharma strategy uniquely combines the reach and resources of a major pharma company with the entrepreneurial spirit and agility of a successful biotech company. With this strategy, we focus on our customers’ needs, giving maximum priority to accelerating pipeline development, delivering sales growth and continuing to manage costs.

The strategy is working. For the past three years, our total return for shareholders, including dividends, has been among the best in the industry. We outperformed most mega pharma companies, diversified companies and pure biotech companies. Reflecting our long-standing commitment to deliver shareholder value, our company has paid dividends to stockholders for more than 300 consecutive quarters.

In addition, we have delivered 13 new medicines to patients since 2002, and we have the possibility of two new approvals in 2012.

Our R&D organization is considered among the most productive in the industry. And the String of Pearls strategy of innovative alliances, partnerships and acquisitions further enhances our internal capabilities. Our full array of pearls encompasses many of our key disease areas, including cancer, cardiovascular disease, immunology, neuroscience and virology.

Pursuing our Mission also means we are working to provide patient access to health care. We are striving to that goal through public/private partnerships like SECURE THE FUTURE, our groundbreaking $150 million program to help confront HIV/AIDS in Africa. In addition, through our patient assistance programs, we provide free medications to qualifying patients with financial hardship in the U.S.

Innovation is critical for successfully executing our BioPharma strategy. That innovation is enhanced by a diverse workforce and an inclusive culture. Bristol-Myers Squibb has been recognized year after year as one of the best companies for female executives and working mothers. We’ve also been recognized by the Human Rights Campaign Foundation’s Corporate Equality Index for achieving a perfect score for four consecutive years.

Preservation of our natural resources also represents one of our key commitments. At many of our facilities worldwide, our company is integrating comprehensive energy management, pollution controls and other practices to reduce environmental impacts. Bristol-Myers Squibb is recognized among the leading sustainability-driven companies.

Bristol-Myers Squibb delivers on its commitments: to our patients and customers, to our employees, to our global communities, to our shareholders and to our environment.

Ultimately, our success as a BioPharma leader is measured by the difference we make in the lives of patients. I invite you to listen to some of those stories – which may also be those of our own employees – throughout our website and on